MedPath

Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing Radiotherapy

Not Applicable
Completed
Conditions
Prostate Cancer
Head and Neck Cancer
Rectum Cancer
Interventions
Behavioral: Resistance training
Behavioral: High-intensity interval training
Registration Number
NCT03252821
Lead Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Brief Summary

The aim of this study is to assess the impact of a high-intensity aerobic training and resistance training on fatigue in prostate, head and neck and rectum cancer patients undergoing radiotherapy.

A three-arm randomized controlled trial will be conducted. Patients will be randomised into either a high-intensity aerobic training group or a resistance training group or a control group. Participants in the training groups will exercised for five to eight weeks. Exercise sessions will be take place 3 days per week under the supervision of an experienced therapist. Subjects will be assessed at baseline and post-intervention. The primary outcome will be fatigue measured using the FACIT-fatigue questionnaire. The secondary outcomes will be: functional capacity, quality of life, executive functions, sleep disturbances, somnolence syndrome, insomnia, depression symptoms.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Resistance training groupResistance trainingMuscle strengthening
High-intensity aerobic training groupHigh-intensity interval trainingHigh intensity interval training
Primary Outcome Measures
NameTimeMethod
Change in fatigueAssessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer)

Fatigue is measured by FACIT-fatigue questionnaire

Secondary Outcome Measures
NameTimeMethod
Change in functional capacityAssessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer)

Functional capacity is measured by 6-minute walk test

Change in quality of lifeAssessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer)

Quality of life is measured by Functional Assessment of Cancer Therapy-General

Change in sleep disturbancesAssessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer)

Sleep disturbances are measured by Pittsburgh Sleep Quality Index

Change in somnolence syndromeAssessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer)

Somnolence syndrome is measured by Epworth Sleepiness Scale

Change in insomniaAssessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer)

Insomnia is measured by Insomnia Severity Index

Change in depression symptomsAssessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer)

Depression symptoms are measured by Center for Epidemiologic Studies Depression Scale

Change in executive functionsAssessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer)

Executive functions is measured by the Trail Making Test

Change in dyspneaAssessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer)

Dyspnea is measured by Multidimensional Dyspnea Profile

AdherenceWeekly through the intervention (during 8 weeks)

Percentage of completed sessions

Trial Locations

Locations (1)

Cliniques universitaires Saint-Luc

🇧🇪

Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath